Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Asian Pacific Region

Lacuna Sicav - Adamant Asia Pacific Health

+ Add to Watchlist

LACUAPI:LX

1,706.62 EUR 2.63 0.15%

As of 00:59:30 ET on 01/30/2015.

Snapshot for Lacuna Sicav - Adamant Asia Pacific Health (LACUAPI)

Year To Date: +12.16% 3-Month: +8.76% 3-Year: +21.72% 52-Week Range: 1,210.83 - 1,709.25
1-Month: +12.16% 1-Year: +38.27% 5-Year: - Beta vs MSDEWIN: 0.70

Mutual Fund Chart for LACUAPI

No chart data available.
  • LACUAPI:LX 1,706.62
  • 1M
  • 1Y
Interactive LACUAPI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for LACUAPI

Lacuna Sicav-Adamant Asia Pacific Health is an open-end fund incorporated in Luxembourg. The Fund's objective is growth. The Fund invests at least two-thirds in equities and equity-like securities of companies from the Pacific Rim in the healthcare sector.

Inception Date: 06-21-2011 Telephone: +352 45 13 14 500
Managers: -
Web Site: -

Fundamentals for LACUAPI

NAV (on 2015-01-30) 1,706.62
Assets (M) (on 2015-01-30) 133.35
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment 0.00

Dividends for LACUAPI

No dividends reported

Fees & Expenses for LACUAPI

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.09
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.11

Top Fund Holdings for LACUAPI

Filing Date: 11/28/2014
Name Position Value % of Total
Sawai Pharmaceutical Co Ltd 99,876 4,763,200 4.000%
M3 Inc 258,248 3,572,400 3.000%
Celltrion Inc 124,103 3,572,400 3.000%
Osstem Implant Co Ltd 134,389 3,572,400 3.000%
Otsuka Holdings Co Ltd 140,531 3,572,400 3.000%
Shanghai Fosun Pharmaceutical 1,239,252 3,572,400 3.000%
CSPC Pharmaceutical Group Ltd 4,992,929 3,572,400 3.000%
Dr Reddy's Laboratories Ltd 76,704 3,572,400 3.000%
Lupin Ltd 186,845 3,572,400 3.000%
Glenmark Pharmaceuticals Ltd 337,519 3,572,400 3.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil